J. Decroocq

发表

RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia

D. Birnbaum, P. Gestraud, E. Pasmant, 2022, Leukemia.

APR-246 induces early cell death by ferroptosis in acute myeloid leukemia

J. Tamburini, M. Fontenay, P. Mayeux, 2021, Haematologica.

Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia

Elizabeth C. Townsend, J. Tamburini, D. Weinstock, 2015, Science Advances.

Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia

Elizabeth C. Townsend, J. Tamburini, D. Weinstock, 2015, Science Advances.

Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis

M. Fontenay, D. Bouscary, O. Kosmider, 2021, Blood Cancer Journal.

Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients

M. Fontenay, O. Hermine, V. Asnafi, 2022, Blood Cancer Journal.

PCR‐Fluo‐ASXL1‐FA: A fast, sensitive and inexpensive complementary method to detect ASXL1 mutations in haematological malignancies

O. Kosmider, M. Coudé, L. Darnige, 2022, International journal of laboratory hematology.

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response in multiple myeloma patients

J. Tamburini, L. Chatenoud, O. Schwartz, 2021, medRxiv.

How COVID-19 pandemic has changed haematological care

D. Bouscary, G. Fouquet, J. Decroocq, 2020 .

Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysis.

D. Bouscary, G. Fouquet, E. Grignano, 2022, European journal of cancer care.

Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemia

J. Cayuela, J. Tamburini, D. Bouscary, 2021, Leukemia & lymphoma.

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma

J. Tamburini, L. Chatenoud, O. Schwartz, 2021, Blood.

Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.

S. Demo, J. Tamburini, C. Récher, 2015, Blood.

Etoposide-containing regimens for the treatment of critically ill patients with hematological malignancy-related hemophagocytic lymphohistiocytosis

F. Pène, J. Charpentier, B. Burroni, 2022, Acta oncologica.

AMPK-PERK axis represses oxidative metabolism and enhances apoptotic priming of mitochondria in acute myeloid leukemia.

B. Viollet, A. Lane, J. Tamburini, 2022, Cell reports.

Malignant histiocytosis with a Langerhans cell subtype: A report on the diagnostic and therapeutic challenge.

M. Copin, J. Emile, D. Bouscary, 2021, Blood cells, molecules & diseases.

Rescue Therapy With Romiplostim for Refractory Primary Immune Thrombocytopenia During Pregnancy

L. Marcellin, C. Le Ray, J. Decroocq, 2014, Obstetrics and gynecology.

Clinical outcome of FLAG-IDA chemotherapy sequential with Flu–Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes

D. Blaise, Jiong Hu, R. Devillier, 2018, Bone Marrow Transplantation.

Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone Marrow.

H. Dombret, E. Macintyre, G. Vassiliou, 2020, Cell reports.

J. Bourhis, P. Chevallier, I. Yakoub-Agha, 2018, American journal of hematology.

Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.

J. Soulier, E. Clappier, H. Dombret, 2022, Blood.

Reduced Venetoclax Exposition to Seven Days of Azacitidine Is Efficient in Treatment-Naïve Patients with Acute Myeloid Leukemia

S. de Botton, D. Bouscary, E. Jourdan, 2022, Blood.

RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia

J. Tamburini, P. Auberger, C. Récher, 2018, Leukemia.

Management of patients with multiple myeloma in the era of COVID-19 pandemic: how hospital at home changes our medical practice

D. Bouscary, P. Franchi, J. Decroocq, 2021, Supportive Care in Cancer.

Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era

D. Bouscary, A. Meyer, J. Decroocq, 2022, Viruses.

H. Dombret, P. Fenaux, S. Thépot, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Clinico‐biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi‐centric observational study

J. Tamburini, D. Bouscary, C. Berthon, 2023, British journal of haematology.

P. Pothier, V. Leblond, J. Decroocq, 2014, BMC Infectious Diseases.

Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein

M. Fontenay, D. Bouscary, O. Kosmider, 2023, Cell Death Discovery.

Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM)

S. Choquet, O. Hermine, D. Bouscary, 2023, Cancers.

Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.

S. Demo, J. Tamburini, C. Récher, 2015, Blood.